Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, 143005, India.
Centre for Basic and Translational Research in Health Sciences, Guru Nanak Dev University, Amritsar, 143005, India.
Curr Protein Pept Sci. 2023;24(5):423-435. doi: 10.2174/1389203724666230427112149.
Preterm birth (PTB) (< 37 completed weeks gestation) is a pathological outcome of pregnancy and its associated complications are the leading global cause of death in children younger than 5 years of age. Babies born prematurely have an elevated risk for short- and long-term adverse effects of medical and neurodevelopmental sequelae. Substantial evidence suggests that multiple sets of symptoms are allied with PTB etiology, and the exact mechanism cannot be recognized. Notably, various proteins, especially (i) complement cascade; (ii) immune system; and (iii) clotting cascade, have become attractive research targets that are associated with PTB. Further, a small imbalance of these proteins in maternal or foetal circulation could serve as a marker/precursor in a series of events that lead to PTBs. Thus, the present review lightens the basic description of the circulating proteins, their role in PTB, and current concepts for future development. Further, deepening the research on these proteins will lead to a better understanding of PTB etiology and alleviate scientists' confidence in the early identification of PTB mechanisms and biological markers.
早产(PTB)(<37 周妊娠完成)是妊娠的病理性结局,其相关并发症是 5 岁以下儿童死亡的主要全球原因。早产儿有短期和长期不良医疗和神经发育后遗症的风险增加。大量证据表明,多组症状与 PTB 病因有关,确切的机制尚无法识别。值得注意的是,许多蛋白质,特别是(i)补体级联;(ii)免疫系统;和(iii)凝血级联,已成为与 PTB 相关的有吸引力的研究靶点。此外,母体或胎儿循环中这些蛋白质的微小失衡可能作为一系列导致 PTB 的事件的标志物/前体。因此,本综述强调了循环蛋白的基本描述、它们在 PTB 中的作用以及未来发展的现有概念。此外,深入研究这些蛋白质将有助于更好地了解 PTB 的病因,并增强科学家对早期识别 PTB 机制和生物标志物的信心。